Captrust Financial Advisors Repligen Corp Transaction History

Captrust Financial Advisors

  • $33 Billion
  • Q3 2024

A detailed history of Captrust Financial Advisors transactions in Repligen Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 6,283 shares of RGEN stock, worth $972,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,283
Previous 6,350 1.06%
Holding current value
$972,985
Previous $800,000 16.88%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.79 - $167.35 $8,025 - $11,212
-67 Reduced 1.06%
6,283 $935,000
Q2 2024

Aug 14, 2024
BUY
$120.0 - $182.95 $111,360 - $169,777
928 Added 17.12%
6,350 $800,000
Q1 2024

May 15, 2024
SELL
$170.78 - $208.42 $285,202 - $348,061
-1,670 Reduced 23.55%
5,422 $997,000
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $20,664 - $33,548
181 Added 2.62%
7,092 $1.28 Million
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $272,147 - $346,136
1,961 Added 39.62%
6,911 $1.1 Million
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $220,226 - $286,873
1,591 Added 47.37%
4,950 $700,000
Q1 2023

May 15, 2023
SELL
$154.26 - $198.1 $43,655 - $56,062
-283 Reduced 7.77%
3,359 $565,000
Q4 2022

Feb 15, 2023
SELL
$162.42 - $220.56 $34,757 - $47,199
-214 Reduced 5.55%
3,642 $616,000
Q3 2022

Nov 16, 2022
BUY
$160.42 - $256.21 $232,448 - $371,248
1,449 Added 60.2%
3,856 $721,000
Q2 2022

Aug 23, 2022
SELL
$140.68 - $188.02 $254,068 - $339,564
-1,806 Reduced 42.87%
2,407 $391,000
Q2 2022

Aug 16, 2022
BUY
$140.68 - $188.02 $60,914 - $81,412
433 Added 11.46%
4,213 $684,000
Q1 2022

May 16, 2022
BUY
$161.19 - $257.96 $147,650 - $236,291
916 Added 31.98%
3,780 $711,000
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $30,453 - $37,449
-123 Reduced 4.12%
2,864 $759,000
Q3 2021

Nov 16, 2021
SELL
$194.77 - $324.21 $18,113 - $30,151
-93 Reduced 3.02%
2,987 $863,000
Q2 2021

Aug 16, 2021
SELL
$165.87 - $220.95 $1,990 - $2,651
-12 Reduced 0.39%
3,080 $615,000
Q1 2021

May 17, 2021
BUY
$180.37 - $226.26 $80,445 - $100,911
446 Added 16.86%
3,092 $601,000
Q4 2020

Feb 16, 2021
BUY
$148.08 - $206.57 $133,568 - $186,326
902 Added 51.72%
2,646 $507,000
Q3 2020

Nov 17, 2020
BUY
$122.51 - $158.27 $79,263 - $102,400
647 Added 58.98%
1,744 $261,000
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $103,480 - $154,106
1,097 New
1,097 $136,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.59B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email